Beckman Coulter, Inc. Gets CE Mark for HCV, HIV-1 MDx Tests

NEW YORK (GenomeWeb) – Beckman Coulter said yesterday that it has garnered CE marking for its DxN Veris HCV and DxN Veris HIV-1 assays, quantitative tests for hepatitis C virus RNA and HIV-1 RNA viral load, respectively, in human plasma.

The DxN Veris HCV assay detects HCV genotypes one to six, and is calibrated to the fourth World Health Organization International Standard for HCV.

Help employers find you! Check out all the jobs and post your resume.

Back to news